<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03862781</url>
  </required_header>
  <id_info>
    <org_study_id>2018-139</org_study_id>
    <nct_id>NCT03862781</nct_id>
  </id_info>
  <brief_title>Intra-Corporeal Anastomosis Result in Quicker Return of Bowel Function/Earlier Discharge</brief_title>
  <acronym>RICART</acronym>
  <official_title>Randomized Trial of Intra-Corporeal Anastomosis for RighT Colectomies (RICART Study)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Spectrum Health Hospitals</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Spectrum Health Hospitals</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Adult patients who are regularly scheduled to undergo a right hemicolectomy via a minimally
      invasive approach (robotic or laparoscopic) with the creation of an anastomosis.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of this trial is to investigate whether minimally invasive right colectomies done
      with an intra-corporeal anastomosis result in quicker return of bowel function and earlier
      discharge. The primary endpoint of this study will be return of bowel function as measured by
      passage of flatus and bowel motions. The secondary endpoints will be inpatient length of
      stay, incision length, postoperative narcotic use, surgical site infection (superficial, deep
      and organ-space), perioperative morbidity and operating room charges.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 28, 2019</start_date>
  <completion_date type="Anticipated">January 2022</completion_date>
  <primary_completion_date type="Anticipated">December 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>After the participants have been consented to the study, the study coordinator will refer to the randomization schedule, and alert the surgeon whether creation of the anastomosis will be done in either an intra-corporeal or extra-corporeal fashion.</intervention_model_description>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Single (Participant)</masking>
    <masking_description>The patients, nursing staff and the perioperative care team (physician assistants, residents) will be blinded.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Return of bowel function</measure>
    <time_frame>up to 2 weeks</time_frame>
    <description>Flatus and bowel motions</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Inpatient length of stay</measure>
    <time_frame>up to 2 weeks</time_frame>
    <description>Days in the hospital after surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incision length</measure>
    <time_frame>Surgery date</time_frame>
    <description>cm's</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative narcotic use</measure>
    <time_frame>up to 2 weeks</time_frame>
    <description>Average pain scores over first 5 hospital days</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Surgical site infection</measure>
    <time_frame>up to 6 weeks</time_frame>
    <description>(superficial, deep and organ-space)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Perioperative morbidity</measure>
    <time_frame>Baseline (Prior to surgery)</time_frame>
    <description>Disease state</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Operating room charges</measure>
    <time_frame>Surgery date</time_frame>
    <description>Fees for operating room</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">125</enrollment>
  <condition>Colorectal Disorders</condition>
  <arm_group>
    <arm_group_label>Intra-corporeal</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Right Hemicolectomy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Extra-corporeal</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Right Hemicolectomy</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Right Hemicolectomy</intervention_name>
    <description>Minimally invasive approach (robotic or laparoscopic) with the creation of an anastomosis.</description>
    <arm_group_label>Extra-corporeal</arm_group_label>
    <arm_group_label>Intra-corporeal</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Eligible patients are those over 18 years of age who are regularly scheduled to
             undergo a right hemicolectomy via a minimally invasive approach (robotic or
             laparoscopic) with the creation of an anastomosis. Right colectomy will be defined as
             removal of the ascending colon, ligation of the ileocolic artery and vein, +/- removal
             of the terminal ileum, +/- removal of the proximal transverse colon, and +/- removal
             of the right branch of the middle colic artery and vein.

        Exclusion Criteria:

          -  Pregnant women

          -  Additional colon resection is planned (i.e. left colectomy or proctectomy)

          -  Vulnerable populations such as prisoners or adults unable to give consent

          -  If the scheduled surgery is planned at Butterworth hospital (as to standardize the
             nursing care received postoperatively)

          -  Emergent cases

        Patients will be excluded from the study intra-operatively if:

          -  The procedure is converted to an open resection

          -  If a loop ileostomy is performed in addition to the right colectomy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>James W Ogilvie, Jr., MS</last_name>
    <role>Principal Investigator</role>
    <affiliation>Spectrum Health Hospitals</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Julia E Reddy</last_name>
    <phone>616-486-2022</phone>
    <email>Julia.Reddy@spectrumhealth.org</email>
  </overall_contact>
  <location>
    <facility>
      <name>Spectrum Health Medical Group</name>
      <address>
        <city>Grand Rapids</city>
        <state>Michigan</state>
        <zip>49546</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Julia E Reddy</last_name>
      <phone>616-486-2022</phone>
      <email>Julia.Reddy@spectrumhealth.org</email>
    </contact>
    <investigator>
      <last_name>James Ogilvie, MS</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>February 5, 2019</study_first_submitted>
  <study_first_submitted_qc>March 1, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">March 5, 2019</study_first_posted>
  <last_update_submitted>April 8, 2020</last_update_submitted>
  <last_update_submitted_qc>April 8, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 10, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Spectrum Health Hospitals</investigator_affiliation>
    <investigator_full_name>James W. Ogilvie</investigator_full_name>
    <investigator_title>Colorectal Surgeon</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>There is no plan to Share IPD.</ipd_description>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Informed Consent Form</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>Yes</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>November 12, 2019</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/81/NCT03862781/ICF_001.pdf</document_url>
    </provided_document>
  </provided_document_section>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

